The Cigna Group (NYSE:CI) Shares Purchased by Foster Victor Wealth Advisors LLC

Foster Victor Wealth Advisors LLC boosted its position in The Cigna Group (NYSE:CI) by 4.6% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 45,745 shares of the health services provider’s stock after acquiring an additional 1,997 shares during the period. The Cigna Group comprises approximately 1.1% of Foster Victor Wealth Advisors LLC’s holdings, making the stock its 22nd biggest holding. Foster Victor Wealth Advisors LLC’s holdings in The Cigna Group were worth $15,861,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CI. Trust Co. of Oklahoma grew its stake in shares of The Cigna Group by 6.8% during the 3rd quarter. Trust Co. of Oklahoma now owns 4,825 shares of the health services provider’s stock valued at $1,672,000 after buying an additional 307 shares during the period. Swedbank AB boosted its position in The Cigna Group by 26.6% during the 3rd quarter. Swedbank AB now owns 570,283 shares of the health services provider’s stock worth $197,569,000 after purchasing an additional 119,681 shares during the period. Ulland Investment Advisors LLC boosted its position in The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the period. Allen Mooney & Barnes Investment Advisors LLC acquired a new position in The Cigna Group in the 3rd quarter worth $200,000. Finally, Creative Planning lifted its holdings in The Cigna Group by 7.2% in the 3rd quarter. Creative Planning now owns 59,655 shares of the health services provider’s stock worth $20,667,000 after buying an additional 3,994 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Price Performance

CI opened at $348.91 on Wednesday. The firm has a market cap of $99.12 billion, a price-to-earnings ratio of 28.65, a price-to-earnings-growth ratio of 1.05 and a beta of 0.50. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $370.83. The company’s 50-day moving average price is $349.71 and its 200 day moving average price is $344.46. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73.

The Cigna Group (NYSE:CI) last posted its earnings results on Thursday, August 1st. The health services provider reported $6.72 EPS for the quarter, topping the consensus estimate of $6.42 by $0.30. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The firm had revenue of $60.52 billion during the quarter, compared to analysts’ expectations of $58.30 billion. During the same quarter in the prior year, the firm earned $6.13 EPS. The Cigna Group’s quarterly revenue was up 24.6% on a year-over-year basis. As a group, sell-side analysts expect that The Cigna Group will post 28.48 earnings per share for the current year.

The Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th were given a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Wednesday, September 4th. The Cigna Group’s dividend payout ratio (DPR) is 45.98%.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a report on Tuesday, October 1st. Stephens reiterated an “overweight” rating and issued a $410.00 price objective on shares of The Cigna Group in a report on Friday, August 2nd. JPMorgan Chase & Co. boosted their price objective on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Barclays upped their target price on shares of The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $384.00 target price on shares of The Cigna Group in a research note on Monday, September 9th. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $392.79.

Insider Activity

In other news, Director William J. Delaney III sold 2,691 shares of the stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the transaction, the director now directly owns 17,539 shares in the company, valued at $6,010,264.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.60% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.